Gómez-López, A.; Sánchez-Sánchez, A.; Natera-Villalba, E.; Ros-Castelló, V.; Beltrán-Corbellini, Á.; Fanjul-Arbós, S.; Pareés Moreno, I.; López-Sendon Moreno, J.L.; Martínez Castrillo, J.C.; Alonso-Canovas, A.
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease. Brain Sci. 2021, 11, 57.
https://doi.org/10.3390/brainsci11010057
AMA Style
Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A.
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease. Brain Sciences. 2021; 11(1):57.
https://doi.org/10.3390/brainsci11010057
Chicago/Turabian Style
Gómez-López, Ana, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, and Araceli Alonso-Canovas.
2021. "SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease" Brain Sciences 11, no. 1: 57.
https://doi.org/10.3390/brainsci11010057
APA Style
Gómez-López, A., Sánchez-Sánchez, A., Natera-Villalba, E., Ros-Castelló, V., Beltrán-Corbellini, Á., Fanjul-Arbós, S., Pareés Moreno, I., López-Sendon Moreno, J. L., Martínez Castrillo, J. C., & Alonso-Canovas, A.
(2021). SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease. Brain Sciences, 11(1), 57.
https://doi.org/10.3390/brainsci11010057
